使用系统代谢工程的Klebsiella oxytocaca有效地生产L-氨酸
Menghao Cao1, Weikang Sun1, Shuo Wang1
1State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
Bioresource technology
|January 31, 2024
概括
研究人员对Klebsiella oxytoca进行了高产量L-氨酸生产的工程设计,达到122g/L. 这种代谢工程策略将发酵重定向到有价值的氨基酸合成.
科学领域:
- 代谢工程和合成生物学
- 微生物发酵 微生物发酵
- 生物化学生产 生化生产
背景情况:
- 作为一种必不可少的分支链氨基酸,L-Valine具有多种工业应用.
- 目前的微生物生产方法在产量和效率方面面临挑战.
- 克莱布西拉 (Klebsiella oxytoca) 是一个已知的2,3-butanediol生产者,需要代谢重定向以合成L-瓦林.
研究的目的:
- 为了设计Klebsiella oxytoca,以实现高效的L-氨酸生物合成.
- 将新陈代谢流量从2,3-butanediol转向L-氨酸生产.
- 为了优化高度L-氨酸的发酵条件.
主要方法:
- 在Klebsiella oxytoca中进行代谢流量分析和途径工程.
- 引入外源的L-氨酸生物合成基因.
- 在α-乙酸盐前体处阻断内源的2,3-butanediol通路.
- 增强L-氨酸的流出和pyruvate聚合.
- 构建一个无等离子体的工程菌株 (K. oxytoca VKO-9).
主要成果:
- 工程K. oxytocaVKO-9通过食批发发酵在56小时内产生122g/L的L-氨酸,产量为0.587g/g.
- 重复食批次发酵实现了平均L-氨酸度为81.3g/L,产量为0.599g/g,生产率为3.39g/L/h.
- 代谢重定向成功地将碳流转向L-氨酸合成.
结论:
- 开发的代谢工程策略对于使用Klebsiella oxytoca.高度L-氨酸生产是有效的.
- 优化发酵过程,包括重复食批量,提高生产率,管理产品沉.
- 这种方法为可持续的微生物生产L-氨酸提供了一个有希望的平台.
相关概念视频
Evolution of New Traits in Microbes
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


